Antisense oligodeoxynucleotides directed against aspartyl (asparaginyl) beta-hydroxylase suppress migration of cholangiocarcinoma cells
about
sameAs
Collagen and calcium-binding EGF domains 1 is frequently inactivated in ovarian cancer by aberrant promoter hypermethylation and modulates cell migration and survivalOverexpression of insulin receptor substrate-1 and hepatitis Bx genes causes premalignant alterations in the liverSuppression subtractive hybridization and expression profiling identifies a unique set of genes overexpressed in non-small-cell lung cancerExpression of aspartyl beta-hydroxylase and its clinicopathological significance in hepatocellular carcinomaAlcohol-induced disruption of endocrine signalingDifferential growth factor regulation of aspartyl-(asparaginyl)-beta-hydroxylase family genes in SH-Sy5y human neuroblastoma cells.Upstream stimulatory factors are involved in the P1 promoter directed transcription of the A beta H-J-J locusGenetic and molecular abnormalities in cholangiocarcinogenesis.Development of a novel anti-human aspartyl-(asparaginyl) β-hydroxylase monoclonal antibody with diagnostic and therapeutic potential.Prognostic value of aspartyl (asparaginyl)-beta-hydroxylase/humbug expression in non-small cell lung carcinomaEthanol inhibition of aspartyl-asparaginyl-beta-hydroxylase in fetal alcohol spectrum disorder: potential link to the impairments in central nervous system neuronal migration.Cholangiocarcinoma: modern advances in understanding a deadly old diseaseA cell-surface β-hydroxylase is a biomarker and therapeutic target for hepatocellular carcinomaRole of aspartyl-(asparaginyl)-β-hydroxylase mediated notch signaling in cerebellar development and function.Aspartate β-Hydroxylase expression promotes a malignant pancreatic cellular phenotypeImmunization with aspartate-β-hydroxylase-loaded dendritic cells produces antitumor effects in a rat model of intrahepatic cholangiocarcinoma.Tumor progression-related transmembrane protein aspartate-β-hydroxylase is a target for immunotherapy of hepatocellular carcinoma.Anti-Tumor Effects of Second Generation β-Hydroxylase Inhibitors on Cholangiocarcinoma Development and Progression.Potential Role of Phosphorylation as a Regulator of Aspartyl-(asparaginyl)-β-hydroxylase: Relevance to Infiltrative Spread of Human Hepatocellular Carcinoma.siRNA inhibition of aspartyl-asparaginyl β-hydroxylase expression impairs cell motility, Notch signaling, and fetal growth.PPARdelta agonist attenuates alcohol-induced hepatic insulin resistance and improves liver injury and repair.Impaired placentation in fetal alcohol syndrome.Aspartate-β-hydroxylase (ASPH): A potential therapeutic target in human malignant gliomas.Role of Notch signaling pathway in pancreatic cancer.The role of cancer-associated myofibroblasts in intrahepatic cholangiocarcinoma.Potential Co-Factor Role of Tobacco Specific Nitrosamine Exposures in the Pathogenesis of Fetal Alcohol Spectrum DisorderOverexpression of aspartyl-(asparaginyl)-beta-hydroxylase in hepatocellular carcinoma is associated with worse surgical outcome.Tobacco Nitrosamine Exposures Contribute to Fetal Alcohol Spectrum Disorder Associated Cerebellar Dysgenesis.Ethanol-Induced White Matter Atrophy Is Associated with Impaired Expression of Aspartyl-Asparaginyl-β-Hydroxylase (ASPH) and Notch Signaling in an Experimental Rat Model.Phosphorylation Modulates Aspartyl-(Asparaginyl)-β Hydroxylase Protein Expression, Catalytic Activity and Migration in Human Immature Neuronal Cerebellar Cells.Aspartate beta-hydroxylase promotes cholangiocarcinoma progression by modulating RB1 phosphorylation
P2860
Q24655625-FD352EF4-FBF4-4009-8DFC-6507CAA05129Q28246572-FC269DAC-E638-49BC-A5DC-6A1D29D163F7Q28279309-3243EFBC-D08D-44EC-B900-3BED51262345Q28286169-B190ADE1-316F-46D3-8ED6-A45C953518E2Q28305674-30BE8F1E-5FE8-4032-8B44-EEE1C4A52B92Q33265938-5A69C33C-8E78-442C-8C0D-9F24AD3ED942Q33393444-124838F4-5339-4829-AF5F-E88CC10DE487Q33570262-E0571605-E926-44F3-BF85-B4A92BA100F4Q33599455-2EA3878B-F29C-440B-A9CF-AB70EAED9AFDQ33944587-E1E1028E-9F3E-4C1F-8C11-EA1530835DBDQ33944605-6C87E7C2-F5E1-49B1-84D9-45FAC192C00EQ34000079-93CBD484-BA07-4EE7-B9C9-307D3BDE4D46Q34250364-3E212F60-6274-4820-8B5C-A733F5F71956Q34335246-90E91FC2-8A9D-4FF9-8762-789EAB2995F7Q35176052-FF48CF5A-1D09-4AE2-8C5B-01DA5159F589Q35624314-44B363F2-8AF8-4778-89DB-A7993E6DFC13Q35894880-23AA4483-9005-4770-BBA1-BF3009FE9D0FQ35949450-A3086A28-665D-4ACF-8AC9-038CDB433618Q36170624-DA80F53D-A92A-4BA2-A5CD-33FD5CAE5918Q37023897-FDAD492A-3955-469F-B961-1C83EC451FDBQ37187770-FA23A174-C5C9-483D-9260-1CFA6F0E883CQ37216866-9158ACF0-1AB0-4659-9174-7358C1D3A6C9Q37485171-EBF3B3BA-AEF1-4606-8F95-52BD6697FD81Q37679979-BAE50F52-DCA3-4B8E-8778-4419FE167394Q37964960-3F3DE6E4-C14A-4057-879E-4D0A626757A0Q41513131-A9060A64-58BE-4A47-AED7-45D41434D70CQ43005656-9897271A-6BE0-4A33-A285-8E60530023D9Q47127142-C664BF77-0E7D-429D-A0B0-89B1481DBCEEQ47331366-99EC3ABF-431C-43C3-BB02-6D96A7D3A8A7Q53092252-8719012B-3F3B-4719-A3FA-47460A791C41Q57112122-EBEF5E2C-E664-465C-B294-F072C15A927A
P2860
Antisense oligodeoxynucleotides directed against aspartyl (asparaginyl) beta-hydroxylase suppress migration of cholangiocarcinoma cells
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Antisense oligodeoxynucleotide ...... on of cholangiocarcinoma cells
@ast
Antisense oligodeoxynucleotide ...... on of cholangiocarcinoma cells
@en
Antisense oligodeoxynucleotide ...... on of cholangiocarcinoma cells
@nl
type
label
Antisense oligodeoxynucleotide ...... on of cholangiocarcinoma cells
@ast
Antisense oligodeoxynucleotide ...... on of cholangiocarcinoma cells
@en
Antisense oligodeoxynucleotide ...... on of cholangiocarcinoma cells
@nl
prefLabel
Antisense oligodeoxynucleotide ...... on of cholangiocarcinoma cells
@ast
Antisense oligodeoxynucleotide ...... on of cholangiocarcinoma cells
@en
Antisense oligodeoxynucleotide ...... on of cholangiocarcinoma cells
@nl
P2093
P1476
Antisense oligodeoxynucleotide ...... on of cholangiocarcinoma cells
@en
P2093
Jack R Wands
Munetomo Enjoji
Seishu Tamaki
Stephanie Lahousse
Suzanne M de la Monte
Takashi Maeda
P304
P356
10.1016/S0168-8278(03)00052-7
P407
P577
2003-05-01T00:00:00Z